to make early cancer detection, diagnosis and treatment, more accurate, accessible and affordable.
We are developing an ecosystem, focussed on life sciences to constantly evaluate and improve the efficiency of pharmaceutical and biotechnology companies, reduce R&D costs, and mitigate risks.
A serial entrepreneur, researcher, author, and business strategist. Member of HBR Advisory Council. Received numerous awards for his contribution in healthcare and public health. He has published and lectured extensively on healthcare performance improvement, digitalization, and innovation
Dr. Mesk Alhammadi
Medical Director
A physician and a graduate of Yale University’s Master of Public Health program, with a concentration in Social and Behavioral Sciences. She is also a research assistant in Yale’s Department of Pulmonary, Critical Care & Sleep Medicine. She also led awareness campaigns on Alzheimer’s disease and cardiovascular health, reinforcing her dedication to culturally sensitive, community-based care and participated in several community health initiatives. At Yale, she contributed to the development of breast cancer care pathways at Smilow Cancer Center.
Dr. Rohit Thanki
Director – Technology & Research
Stanford & Elsevier’s Top 2% Global Scientists. Senior AI/ML Scientist with over 15+ years of research experience and 8+ years in regulated MedTech development across Germany, the UAE, and India. Expertise lies at the intersection of AI, medical imaging, regulatory compliance, and healthcare innovation. Published 20+ books, 120+ research articles
Dr. Hashem Mirmazloumi
Genetics & Life Science
Medical geneticist and MBA, a healthcare business advisor , with speciality in Cytogenetics, FISH, and genomics. Over a decade of operation management, commercial development, and business strategy in the Middle East and Asia.
Sabitha K.
AI / ML Scientist
M.E. in Biomedical Engg, B.E. in Comp. Sci. 8+ years of R & D experience in AI/ML in healthcare
Dr. Sten Vermund, MD, PhD
President, Anna M.R. Lauder Professor of Public Health Former Dean (2017-2022) of the Yale School of Public Health Infectious disease epidemiologist focused on LMIC
Dr. Douglas Anthony, MD, PhD
Professor of Pathology and Laboratory Medicine Professor of Neurology at Alpert Medical School of Brown University Associate Director for Translational Research at Lifespan Cancer Institute
Dr. Uma Nambiar
Executive Director, Gimcare Hospital, Consultant-Bagchi Parthasarthy Hospital & IISc Medical School Chairperson DHIndia Association.
Dr. Ibrahim Bani, MBBS, PhD
Adjunct Associate Professor at Yale University Associate Professor at Ajman University, UAE Worked with international Agencies WHO, UN, MI, UNC
Dr. Keerti Pradhan
Experienced in health sector program development, strategy, planning and management, working for Government, Private, Charity and Corporate groups in the Asian and African countries.
